Search Within

Brian Carl Shaffer

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Meeting Abstract (17)
  2. Journal Article (13)
  3. Research Letter (1)
  4. Review (1)
Groups
  1. Bone Marrow Transplant (32)
  2. Center for Hematologic Malignancies (32)
  3. Department of Medicine (32)
  4. GSK Faculty (32)
  5. Hematologic Malignancies, Division of (32)
  6. Human Oncology and Pathogenesis Program (32)

More Groups

People
  1. Sergio Giralt (23)
  2. Esperanza Papadopoulos (19)
  3. Miguel-Angel Perales (19)
  4. Boglarka Gyurkocza (18)
  5. Ann Jakubowski (16)
  6. Roni Tamari (16)

More People

Years
  1. 2025 (1)
  2. 2023 (3)
  3. 2022 (1)
  4. 2021 (3)
  5. 2020 (5)
  6. 2019 (1)

More Years

Publications
  1. Blood (9)
  2. Biology of Blood and Marrow Transplantation (7)
  3. Blood Advances (6)
  4. American Journal of Hematology (2)
  5. Advances in Cell and Gene Therapy (1)
  6. Best Practice and Research: Clinical Haematology (1)

More Publications

Publishers
  1. American Society of Hematology (15)
  2. Elsevier Inc. (8)
  3. John Wiley & Sons, Inc. (2)
  4. American Association for the Advancement of Science (1)
  5. American Society of Clinical Oncology (1)
  6. John Wiley & Sons (1)

More Publishers

Results (32)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 2 trial of cyclosporine-A, mycophenolate mofetil, and tocilizumab GVHD prophylaxis in cord blood transplantation
    Journal Article

    Politikos, I.; Brown, S.; Fein, J. A.; Eng, S.; Casem, K.; Chinapen, S.; Quach, S.; Scaradavou, A.; Cho, C.; Dahi, P.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • SHLA-DRB1 HED is associated with improved survival and decreased relapse in patients with hematologic malignancies following allogeneic hematopoietic stem cell transplant
    Meeting Abstract

    Camacho-Bydume, C.; Wang, T.; Chowell, D.; Krishna, C.; Shaffer, B. C.; Marsh, S.; Paczesny, S.; Gadalla, S. M.; He, M.; Bolon, Y. T.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Emergence of human CMV-induced NKG2C(+) NK cells is associated with CD8(+) T-cell recovery after allogeneic HCT
    Journal Article

    van der Ploeg, K.; Sottile, R.; Kontopoulos, T.; Shaffer, B. C.; Papanicolaou, G. A.; Maloy, M. A.; Cho, C.; Robinson, K. S.; Perales, M. A.; Jean-Benoît, L. L.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Molecular predictors of immunophenotypic measurable residual disease clearance in acute myeloid leukemia
    Journal Article

    Stahl, M.; Derkach, A.; Farnoud, N.; Bewersdorf, J. P.; Robinson, T.; Famulare, C.; Cho, C.; Devlin, S.; Menghrajani, K.; Patel, M. A.; more...
    American Journal of Hematology (2023)

    Fulltext@MSK | Save
  • Tracking immune reconstitution in the bone marrow following allogeneic hematopoietic transplantation in humans reveals early dominance of innate lymphoid populations
    Meeting Abstract

    DeWolf, S.; Kuttiyara, J.; Vinci, P.; Slingerland, J.; Marcello, L. T.; Giardina, P. A.; Donohoe, W.; Lin, R. J.; Papadopoulos, E. B.; Gyurkocza, B.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Combining the Disease Risk Index and Hematopoietic Cell Transplant Co-Morbidity Index provides a comprehensive prognostic model for CD34(+)-selected allogeneic transplantation
    Journal Article

    Cho, C.; Hilden, P.; Avecilla, S. T.; Barker, J. N.; Castro-Malaspina, H.; Giralt, S. A.; Gyurkocza, B.; Jakubowski, A. A.; Maloy, M. A.; O'Reilly, R. J.; more...
    Advances in Cell and Gene Therapy (2021)

    Fulltext@MSK | Save
  • Prospective KIR genotype evaluation of hematopoietic cell donors is feasible with potential to benefit patients with AML
    Journal Article

    Shaffer, B. C.; Le Luduec, J. B.; Park, S.; Devlin, S.; Archer, A.; Davis, E.; Cooper, C.; Nhaissi, M.; Suri, B.; Wells, D.; more...
    Blood Advances (2021)

    Fulltext@MSK | Save
  • The prognosis and durable clearance of RAS mutations in patients with acute myeloid leukemia receiving induction chemotherapy
    Research Letter

    Ball, B. J.; Hsu, M.; Devlin, S. M.; Arcila, M.; Roshal, M.; Zhang, Y.; Famulare, C. A.; Goldberg, A. D.; Cai, S. F.; Dunbar, A.; more...
    American Journal of Hematology (2021)

    Fulltext@MSK | Save
  • Molecular predictors and effectiveness of measurable residual disease (MRD) eradication with chemotherapy and allogeneic stem cell transplantation for acute myeloid leukemia
    Meeting Abstract

    Stahl, M.; Derkach, A.; Famulare, C.; Cho, C.; Devlin, S.; Farnoud, N.; Menghrajani, K.; Patel, M. A.; Cai, S. F.; Geyer, M. B.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Selection of allogeneic hematopoietic cell transplant donors to optimize natural killer cell alloreactivity
    Review

    Shaffer, B. C.; Hsu, K. C.
    Seminars in Hematology (2020)

    Fulltext@MSK | Save